RS50628B - Derivati(poli)aminoacetamida epipodofilotoksina, postupak za njihovo dobijanje i njihove primene u terapeutici kao sredstva protiv kancera - Google Patents

Derivati(poli)aminoacetamida epipodofilotoksina, postupak za njihovo dobijanje i njihove primene u terapeutici kao sredstva protiv kancera

Info

Publication number
RS50628B
RS50628B RSP-2008/0494A RSP20080494A RS50628B RS 50628 B RS50628 B RS 50628B RS P20080494 A RSP20080494 A RS P20080494A RS 50628 B RS50628 B RS 50628B
Authority
RS
Serbia
Prior art keywords
radical
group
hydrogen atom
independently
alkyl radical
Prior art date
Application number
RSP-2008/0494A
Other languages
English (en)
Inventor
Thierry Imbert
Yves Guminski
Jean-Marc Barret
Anna Kruczinski
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of RS50628B publication Critical patent/RS50628B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Jedinjenja opšte formule (I) u kojojR1 i R2 predstavljaju, nezavisno jedan od drugog, atom vodonika ili metil radikal; R3 i A zajedno formiraju C3-C8 prsteniliR3 predstavlja radikal odabran iz grupe koja sadrži atom vodonika, C1-C4 alkil radikal i benzil radikal, a A predstavlja radikal odabran iz grupe koja sadrži atom vodonika, C1-C4 alkil radikal, benzil radikal i grupu formule (II) u kojoja varira od 2 do 5,R4 i B zajedno formiraju C3-C8 prsten iliR4 predstavlja radikal odabran iz grupe koja sadrži atom vodonika, C1-C4 alkil radikal i benzil radikal, gde R3 i R4 mogu da budu spojeni alkilenskim lancem koji sadrži 2 ili 3 atoma ugljenika, a B predstavlja radikal odabran iz grupe koja sadrži:- atom vodonika,- C1-C4 alkil radikal,- benzil radikal,- grupu formule (III)u kojoj b i c mogu da variraju, nezavisno jedan od drugog, od 2 do 5, a R5 do R7 predstavljaju, nezavisno jedan od drugog, radikal odabran iz grupe koja sadrži atom vodonika, C1-C4 alkil radikal i benzil radikal, gde R4 i R5 i/ili R5 i R6 i/ili R6 i R7 mogu da budu spojeni alkilenskim lancem koji sadrži 2 ili 3 atoma ugljenika;- i grupu formule (IV)u kojoj c može da varira od 2 do 5, a R8 i R9 predstavljaju, nezavisno jedan od drugog, atom vodonika ili C1-C5 alkil radikal, gde R4 i R8 mogu da budu spojeni alkilenskim lancem koji sadrži 2 ili 3 atoma ugljenika, ili R8 i R9 zajedno formiraju C3-C8 prsten; ili njihove farmaceutski prihvatljive soli, naročito njihove adicione soli, sa neorganskim ili organskim kiselinama. Prijava sadrži još 13 patentnih zahteva.
RSP-2008/0494A 2004-04-16 2005-04-14 Derivati(poli)aminoacetamida epipodofilotoksina, postupak za njihovo dobijanje i njihove primene u terapeutici kao sredstva protiv kancera RS50628B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0404053A FR2869035B1 (fr) 2004-04-16 2004-04-16 Derives (poly)aminoalkylaminoacetamide d'epipodophyllotoxine leur procede de preparation et leurs applications en therapeutique comme agent anticancereux
PCT/IB2005/001268 WO2005100363A1 (en) 2004-04-16 2005-04-14 (poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents

Publications (1)

Publication Number Publication Date
RS50628B true RS50628B (sr) 2010-06-30

Family

ID=34944659

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2008/0494A RS50628B (sr) 2004-04-16 2005-04-14 Derivati(poli)aminoacetamida epipodofilotoksina, postupak za njihovo dobijanje i njihove primene u terapeutici kao sredstva protiv kancera

Country Status (25)

Country Link
US (3) US7846926B2 (sr)
EP (1) EP1742952B1 (sr)
JP (1) JP4876070B2 (sr)
CN (1) CN1946727B (sr)
AR (1) AR048607A1 (sr)
AT (1) ATE402938T1 (sr)
AU (1) AU2005233382C1 (sr)
BR (1) BRPI0509912B8 (sr)
CA (1) CA2562617C (sr)
CY (1) CY1108444T1 (sr)
DE (1) DE602005008578D1 (sr)
DK (1) DK1742952T3 (sr)
ES (1) ES2311985T3 (sr)
FR (1) FR2869035B1 (sr)
HK (1) HK1095812A1 (sr)
HR (1) HRP20080542T3 (sr)
MX (1) MXPA06011886A (sr)
MY (1) MY137712A (sr)
PL (1) PL1742952T3 (sr)
PT (1) PT1742952E (sr)
RS (1) RS50628B (sr)
SI (1) SI1742952T1 (sr)
TW (1) TWI350288B (sr)
WO (1) WO2005100363A1 (sr)
ZA (1) ZA200609055B (sr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2888849B1 (fr) * 2005-07-19 2007-10-05 Pierre Fabre Medicament Sa Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine
FR2919287B1 (fr) * 2007-07-26 2012-10-12 Pf Medicament Nouveaux derives fluorescents de polyamines, leur procede de preparation et leurs applications en tant qu'outils de diagnostic dans le traitement des tumeurs cancereuses.
FR2921369B1 (fr) * 2007-09-25 2014-07-11 Pf Medicament Nouveau procede de preparation de derives (poly) aminoalkylaminoacetamide d'epipodophyllotoxine,utiles pour leurs applications en therapeutique comme agent anticancereux.
FR2921368B1 (fr) * 2007-09-25 2012-10-12 Pf Medicament Nouveau procede de synthese de derives anticancereux de (poly) aminoalkylaminoacetamide d'epipodophyllotoxine.
FR2935143B1 (fr) * 2008-08-19 2010-12-03 Pf Medicament Nouveaus derives (poly)aminoalkylaminoalkylamides, alkyl-urees, ou alkyl-sulfonamides d'epipodophyllotoxine, leur procede de preparation et leur application en therapeuthique comme agent cancereux
EP2373702B1 (en) 2008-12-31 2018-03-21 W.R. Grace & Co.-Conn. Procatalyst composition with substituted 1,2-phenylene aromatic diester internal donor and method
WO2010078479A1 (en) 2008-12-31 2010-07-08 Dow Global Technologies Inc. Random propylene copolymer compositions, articles and process
BR112012013286B1 (pt) * 2009-12-02 2020-03-10 W. R. Grace & Co. - Conn Componente catalisador sólido insolúvel em hidrocarboneto e método para polimerizar uma olefina
EP2507269B1 (en) 2009-12-02 2014-10-29 W.R. Grace & Co.-Conn. Three and four atom bridged dicarbonate compounds as internal donors in catalysts for polypropylene manufacture
CN102234283B (zh) * 2010-04-23 2013-06-12 湖北工业大学 4′-去甲基表鬼臼毒素衍生物及其合成方法和应用
EP2638047B1 (en) * 2010-11-11 2014-07-16 Council of Scientific and Industrial Research "substituted 4-beta-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof"
FR2967675B1 (fr) 2010-11-24 2015-02-27 Pf Medicament Derives fluorescents de cyanines polyamines en tant que sonde de diagnostic
CN105037379B (zh) * 2014-04-25 2017-12-19 上海医药工业研究院 鬼臼毒素衍生物、其制备方法、药物组合物及应用
CN104926841A (zh) * 2015-06-30 2015-09-23 遵义医学院 青蒿琥酯与鬼臼毒素偶联物在抗白血病药物中的应用及制备方法
WO2018234574A1 (en) 2017-06-22 2018-12-27 Ygm Consult Sas COMBINATORY THERAPY FOR THE TREATMENT OF CANCER
CN113801129A (zh) * 2021-09-30 2021-12-17 大连民族大学 一种鬼臼毒素脂质衍生物、纳米载体及其制备方法和在肿瘤治疗中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323884A (ja) * 1986-07-17 1988-02-01 Nippon Kayaku Co Ltd 新規ポドフイロトキシン誘導体
US5300500A (en) * 1989-02-23 1994-04-05 The University Of North Carolina At Chapel Hill 4 beta-amino podophyllotoxin analog compounds and methods
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
CN1068330A (zh) * 1991-07-03 1993-01-27 国家医药管理局上海医药工业研究院 4-氮取代-4-脱氧-4′-去甲表鬼臼毒素衍生物及其合成方法
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
FR2742439B1 (fr) 1995-12-14 1998-03-06 Pf Medicament Procede de preparation de la 4'-demethylepipodophyllotoxine a partir de la podophyllotoxine
FR2810321B1 (fr) 2000-06-20 2002-07-26 Adir Nouveaux derives de podophyllotoxine carbamate et thiocarbamate, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE60205470T2 (de) * 2002-03-28 2006-05-24 Council Of Scientific And Industrial Research Analoge von 4-beta-1''-[(2''-(substitutierte-benzoyl)anilin]-podophyllotoxin zur verwendung als antikrebs-agentia 4-beta-1"-∫2"-(substituted benzoyl) anilino∫ podophyllotoxin analogues useful as anticancer agents
US6566393B1 (en) * 2002-06-21 2003-05-20 The University Of North Carolina At Chapel Hill Etoposide analogs and methods of use thereof
EP1603474B1 (en) 2003-02-14 2013-09-11 The Board Of Trustees Of The Leland Stanford Junior University Electrosurgical system with uniformly enhanced electric field and minimal collateral damage
US20070066837A1 (en) 2003-02-18 2007-03-22 Ahmed Kamal Podophyllotoxin derivatives as antitumor agents

Also Published As

Publication number Publication date
BRPI0509912B8 (pt) 2021-05-25
MXPA06011886A (es) 2006-12-14
CN1946727B (zh) 2010-08-11
US9216989B2 (en) 2015-12-22
ES2311985T3 (es) 2009-02-16
MY137712A (en) 2009-02-27
CA2562617C (en) 2013-06-11
PL1742952T3 (pl) 2009-01-30
HRP20080542T3 (en) 2008-12-31
US20150368258A1 (en) 2015-12-24
US7846926B2 (en) 2010-12-07
JP4876070B2 (ja) 2012-02-15
BRPI0509912A (pt) 2007-09-18
PT1742952E (pt) 2008-10-27
TW200604191A (en) 2006-02-01
US9403840B2 (en) 2016-08-02
WO2005100363A8 (en) 2006-10-26
FR2869035B1 (fr) 2006-07-14
EP1742952A1 (en) 2007-01-17
CA2562617A1 (en) 2005-10-27
CY1108444T1 (el) 2014-04-09
JP2007532628A (ja) 2007-11-15
EP1742952B1 (en) 2008-07-30
TWI350288B (en) 2011-10-11
CN1946727A (zh) 2007-04-11
ATE402938T1 (de) 2008-08-15
BRPI0509912B1 (pt) 2019-08-27
US20090170843A1 (en) 2009-07-02
AR048607A1 (es) 2006-05-10
WO2005100363A1 (en) 2005-10-27
US20110053967A1 (en) 2011-03-03
AU2005233382A1 (en) 2005-10-27
AU2005233382C1 (en) 2010-02-04
SI1742952T1 (sl) 2008-12-31
DE602005008578D1 (de) 2008-09-11
ZA200609055B (en) 2008-06-25
AU2005233382B2 (en) 2009-07-16
FR2869035A1 (fr) 2005-10-21
HK1095812A1 (en) 2007-05-18
DK1742952T3 (da) 2008-10-27

Similar Documents

Publication Publication Date Title
RS50628B (sr) Derivati(poli)aminoacetamida epipodofilotoksina, postupak za njihovo dobijanje i njihove primene u terapeutici kao sredstva protiv kancera
DE602005023015D1 (de) Indolderivate als viruzide
TW200745034A (en) New compounds
RS50537B (sr) Derivati benzimidazola i njihovo korišćenje kao antagonista receptora a ii
MY138941A (en) Aryl-pyridine derivatives
ATE508747T1 (de) C-kit kinase-hemmer
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
MX2009010024A (es) Nuevo compuesto de adenina.
BRPI0409938A (pt) derivados de azetidinacarboxamida e seu uso em terapia
AR057894A1 (es) Derivados de tiofeno
RS53379B (sr) Derivati n-fenil-2-pirimidin-amina i postupak za njihovo pripremanje
ECSP099371A (es) INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA
RS52881B (sr) Benzamidinska jedinjenja koja su korisna kao inhibitori histonske deacetilaze
ATE518824T1 (de) Substituierte cyclohexylmethyl-derivate
NO20090270L (no) Cinnamoyl-piperazinederivater og deres anvendelse som PAR-I-antagonister
ECSP077402A (es) Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
TW200728298A (en) Thiophene compounds and thrombopoietin receptor activators
ATE396183T1 (de) Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
MY146939A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
AR049547A1 (es) Profarmacos de esteroides con accion androgenica
MX2009005366A (es) Derivados de pirrol, su preparacion y su utilizacion en terapeutica.
MX2010008448A (es) Compuesto de bencilpiperizina.
ATE465151T1 (de) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren